Astellas Pharma | 4503 - Ebitda

Stock Price
2,347.50
Daily Change
-14.00 -0.59%
Monthly
-3.18%
Yearly
58.61%
Q1 Forecast
2,263.03

Astellas Pharma reported JPY183.68B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Astellas Pharma JPY 183.68B 31.98B Dec/2025
Chugai Pharma JPY 169.01B 12.52B Dec/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY 30.1B 6.62B Dec/2025
Kyowa Hakko Kirin JPY 45.74B 13.46B Dec/2025
M3 JPY 30.4B 14.73B Dec/2025
Otsuka Holdings JPY 99.77B 94.02B Dec/2025
Shionogi JPY 80B 35.17B Dec/2025
Sumitomo Dainippon JPY 80.4B 54.16B Sep/2025
Takeda JPY 448.13B 173.98B Dec/2025
Terumo JPY 69.99B 3.22B Dec/2025